Data / Drug companies / MSD International GmbH
MSD International GmbH: 14 products in the FDA NDC directory, labeler code 50473
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
MSD International GmbH (labeler code 50473) lists 14 products in the FDA National Drug Code Directory. By type: 8 drugs for further processing, 6 bulk ingredients. Its main marketing category is drugs for further processing. The newest product started marketing on April 20, 2026.
The request: Watch MSD International GmbH (FDA labeler code 50473): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 50473
- Products in commercial distribution
- 14
- Packages
- 14
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 1
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- July 26, 2002
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 8 | 57.1% |
| Bulk ingredients | 6 | 42.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 8 | 57.1% |
| Bulk ingredients | 6 | 42.9% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 8 | 57.1% |
| Powder | 6 | 42.9% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Islatravir monohydrate | 50473-0935 | Powder | Bulk ingredients | April 20, 2026 |
| Doravirine and islatravir monohydrate | 50473-0934 | Tablet, film coated | Drugs for further processing | April 20, 2026 |
| Enlicitide decanoate | 50473-0936 | Powder | Bulk ingredients | February 11, 2026 |
| Belzutifan | 50473-0133 | Tablet, film coated | Drugs for further processing | July 15, 2021 |
| Doravirine, lamivudine, and tenofovir disoproxil fumarate | 50473-0125 | Tablet, film coated | Drugs for further processing | August 30, 2018 |
| Doravirine | 50473-0124 | Tablet, film coated | Drugs for further processing | August 30, 2018 |
| Letermovir | 50473-0127 | Tablet, film coated | Drugs for further processing | November 8, 2017 |
| Letermovir | 50473-0126 | Tablet, film coated | Drugs for further processing | November 8, 2017 |
| Grazoprevir | 50473-0098 | Powder | Bulk ingredients | January 28, 2016 |
| Elbasvir | 50473-0097 | Powder | Bulk ingredients | January 28, 2016 |
| Elbasvir and grazoprevir | 50473-0091 | Tablet, film coated | Drugs for further processing | January 28, 2016 |
| Suvorexant | 50473-0029 | Powder | Bulk ingredients | December 1, 2012 |
| Raltegravir potassium | 50473-0001 | Tablet, film coated | Drugs for further processing | October 12, 2007 |
| Montelukast sodium | 50473-0002 | Powder | Bulk ingredients | July 26, 2002 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.